Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
18,28 GBX | +0,15 % | +2,51 % | -74,01 % |
25/04 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 | |
25/04 | APUNTAR GANADORES Y PERDEDORES: Kromek salta un 14% gracias a un contrato del gobierno estadounidense | AN |
Resumen de negocios
Número de empleados: 24
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 59 | 01/09/23 | |
William Love
FOU | Founder | 62 | 04/03/96 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 24/10/18 |
Jim Lees
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Chief Tech/Sci/R&D Officer | - | 01/01/98 | |
Yuri Martina
CTO | Chief Tech/Sci/R&D Officer | - | 03/05/22 |
Director/Board Member | 61 | 01/01/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Anthony Rudd
CHM | Chairman | 76 | 01/09/11 |
William Love
FOU | Founder | 62 | 04/03/96 |
Nigel Brooksby
BRD | Director/Board Member | - | 01/06/22 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 24/10/18 |
Director/Board Member | 61 | 01/01/20 | |
James Stearns
BRD | Director/Board Member | - | 01/06/22 |
Aled Williams
BRD | Director/Board Member | - | 01/06/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 95 311 863 | 71 818 619 ( 75,35 %) | 0 | 75,35 % |
Información de la empresa
Destiny Pharma Plc
Sussex Innovation Centre Science Park Square
BN1 9SB, Brighton
+44 1273 704440
http://www.destinypharma.comSector
Revisiones del BPA
Beneficios anuales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-74,01 % | 21,87 M | |
+9,15 % | 106 mil M | |
-1,08 % | 104 mil M | |
+6,81 % | 23,25 mil M | |
-11,55 % | 22,5 mil M | |
-7,10 % | 18,7 mil M | |
-37,08 % | 17,95 mil M | |
-9,91 % | 16,99 mil M | |
+7,55 % | 14,26 mil M | |
+40,04 % | 12,76 mil M |
- Bolsa de valores
- Acciones
- Acción DEST
- Empresa Destiny Pharma plc